ASX - By Stock
|
RCE |
Re:
News: RCE Recce Pharmaceuticals Establishes Strategic Partnership In South-East Asia
|
|
Bpharma
|
30 |
9.4K |
3 |
04/10/24 |
04/10/24 |
ASX - By Stock
|
30
|
9.4K
|
3
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
Bpharma
|
2.1K |
652K |
6 |
04/10/24 |
04/10/24 |
ASX - By Stock
|
2.1K
|
652K
|
6
|
|
ASX - By Stock
|
PVE |
Re:
Ann: PVE Half Year Financial Report 30 June 2024
|
|
Bpharma
|
17 |
5.0K |
2 |
03/10/24 |
03/10/24 |
ASX - By Stock
|
17
|
5.0K
|
2
|
|
ASX - By Stock
|
LMG |
Re:
general discussion
|
|
Bpharma
|
2.4K |
1.1M |
2 |
02/10/24 |
02/10/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
2
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
Bpharma
|
2.1K |
652K |
1 |
02/10/24 |
02/10/24 |
ASX - By Stock
|
2.1K
|
652K
|
1
|
|
ASX - By Stock
|
KTA |
Re:
Ann: Mt Clere Nb-REE Gravity Target Continues to Emerge
|
|
Bpharma
|
16 |
16K |
0 |
01/10/24 |
01/10/24 |
ASX - By Stock
|
16
|
16K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
News: RCE Recce Pharmaceuticals Establishes Strategic Partnership In South-East Asia
|
|
Bpharma
|
30 |
9.4K |
4 |
30/09/24 |
30/09/24 |
ASX - By Stock
|
30
|
9.4K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
News: RCE Recce Pharmaceuticals Establishes Strategic Partnership In South-East Asia
|
|
Bpharma
|
30 |
9.4K |
2 |
27/09/24 |
27/09/24 |
ASX - By Stock
|
30
|
9.4K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
News: RCE Recce Pharmaceuticals Establishes Strategic Partnership In South-East Asia
|
|
Bpharma
|
30 |
9.4K |
11 |
26/09/24 |
26/09/24 |
ASX - By Stock
|
30
|
9.4K
|
11
|
|
ASX - By Stock
|
RCE |
Re:
News: RCE Recce Pharmaceuticals Establishes Strategic Partnership In South-East Asia
|
|
Bpharma
|
30 |
9.4K |
7 |
26/09/24 |
26/09/24 |
ASX - By Stock
|
30
|
9.4K
|
7
|
|
ASX - By Stock
|
RCE |
Re:
News: RCE Recce Pharmaceuticals Establishes Strategic Partnership In South-East Asia
|
|
Bpharma
|
30 |
9.4K |
9 |
26/09/24 |
26/09/24 |
ASX - By Stock
|
30
|
9.4K
|
9
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR RECEIVES POSITIVE RESPONSE FROM US FDA FOR PHASE 3
|
|
Bpharma
|
487 |
139K |
1 |
25/09/24 |
25/09/24 |
ASX - By Stock
|
487
|
139K
|
1
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Galactica - Pegasus OGDP I Update
|
|
Bpharma
|
16 |
6.9K |
5 |
20/09/24 |
20/09/24 |
ASX - By Stock
|
16
|
6.9K
|
5
|
|
ASX - By Stock
|
5EA |
Re:
5EA set to skyrocket
|
|
Bpharma
|
1.9K |
970K |
0 |
20/09/24 |
20/09/24 |
ASX - By Stock
|
1.9K
|
970K
|
0
|
|
ASX - By Stock
|
LMG |
Re:
general discussion
|
|
Bpharma
|
2.4K |
1.1M |
0 |
19/09/24 |
19/09/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
0
|
|
ASX - By Stock
|
LMG |
Re:
general discussion
|
|
Bpharma
|
2.4K |
1.1M |
0 |
19/09/24 |
19/09/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
0
|
|
ASX - By Stock
|
PVE |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
Bpharma
|
15 |
7.3K |
4 |
11/09/24 |
11/09/24 |
ASX - By Stock
|
15
|
7.3K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Annual Report to Shareholders
|
|
Bpharma
|
12 |
7.8K |
32 |
06/09/24 |
06/09/24 |
ASX - By Stock
|
12
|
7.8K
|
32
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Trading Halt
|
|
Bpharma
|
12 |
5.0K |
5 |
03/09/24 |
03/09/24 |
ASX - By Stock
|
12
|
5.0K
|
5
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Trading Halt
|
|
Bpharma
|
12 |
5.0K |
3 |
03/09/24 |
03/09/24 |
ASX - By Stock
|
12
|
5.0K
|
3
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Helium One Farms into Galactica / Pegasus Project
|
|
Bpharma
|
12 |
5.3K |
2 |
28/08/24 |
28/08/24 |
ASX - By Stock
|
12
|
5.3K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Application for quotation of securities - RCE
|
|
Bpharma
|
12 |
6.4K |
1 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
12
|
6.4K
|
1
|
|
ASX - By Stock
|
LMG |
Re:
general discussion
|
|
Bpharma
|
2.4K |
1.1M |
1 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
1
|
|
ASX - By Stock
|
LMG |
Re:
Ann: July Company Update
|
|
Bpharma
|
22 |
11K |
0 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
22
|
11K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Application for quotation of securities - RCE
|
|
Bpharma
|
12 |
6.4K |
2 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
12
|
6.4K
|
2
|
|
ASX - By Stock
|
BNL |
Re:
chart
|
|
Bpharma
|
25 |
10K |
0 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
25
|
10K
|
0
|
|
ASX - By Stock
|
BNL |
Re:
chart
|
|
Bpharma
|
25 |
10K |
4 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
25
|
10K
|
4
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Significant Helium Discovery at State 16 Well
|
|
Bpharma
|
191 |
64K |
8 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
191
|
64K
|
8
|
|
ASX - By Stock
|
RCE |
Re:
Ann: US Department of Defense Grants US $2m for R327G
|
|
Bpharma
|
10 |
6.2K |
10 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
10
|
6.2K
|
10
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Significant Helium Discovery at State 16 Well
|
|
Bpharma
|
191 |
64K |
2 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
191
|
64K
|
2
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Significant Helium Discovery at State 16 Well
|
|
Bpharma
|
191 |
64K |
3 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
191
|
64K
|
3
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Significant Helium Discovery at State 16 Well
|
|
Bpharma
|
191 |
64K |
2 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
191
|
64K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: R327 Efficacy against WHO Priority Pathogen Acinetobacter B
|
|
Bpharma
|
22 |
9.8K |
1 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
22
|
9.8K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: R327 Efficacy against WHO Priority Pathogen Acinetobacter B
|
|
Bpharma
|
22 |
9.8K |
5 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
22
|
9.8K
|
5
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Phase I/II UTI/Urosepsis Rapid Infusion Trial Complete
|
|
Bpharma
|
72 |
21K |
2 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
72
|
21K
|
2
|
|
ASX - By Stock
|
CND |
Re:
CND chart
|
|
Bpharma
|
45 |
14K |
2 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
45
|
14K
|
2
|
|
ASX - By Stock
|
PVE |
Re:
Ann: PVE - Podere Maiar-1 Slick Line Operations Results
|
|
Bpharma
|
3 |
2.1K |
2 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
3
|
2.1K
|
2
|
|
ASX - By Stock
|
LMG |
Re:
Ann: LMG Entitlement Offer closing date extended
|
|
Bpharma
|
6 |
4.8K |
3 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
6
|
4.8K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Phase I/II UTI/Urosepsis Rapid Infusion Trial Complete
|
|
Bpharma
|
72 |
21K |
5 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
72
|
21K
|
5
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Phase I/II UTI/Urosepsis Rapid Infusion Trial Complete
|
|
Bpharma
|
72 |
21K |
3 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
72
|
21K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Phase I/II UTI/Urosepsis Rapid Infusion Trial Complete
|
|
Bpharma
|
72 |
21K |
7 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
72
|
21K
|
7
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Significant Helium Discovery at State 16 Well
|
|
Bpharma
|
191 |
64K |
3 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
191
|
64K
|
3
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Significant Helium Discovery at State 16 Well
|
|
Bpharma
|
191 |
64K |
4 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
191
|
64K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Ethics Approval Broadens to All Topical Infections
|
|
Bpharma
|
17 |
5.0K |
9 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
17
|
5.0K
|
9
|
|
ASX - By Stock
|
RCE |
Re:
Ann: R327 added to WHO List of Antibacterial Products
|
|
Bpharma
|
25 |
8.7K |
7 |
22/06/24 |
22/06/24 |
ASX - By Stock
|
25
|
8.7K
|
7
|
|
ASX - By Stock
|
EUR |
Re:
Initial investors returning to the roost
|
|
Bpharma
|
127 |
42K |
0 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
127
|
42K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: R327 added to WHO List of Antibacterial Products
|
|
Bpharma
|
25 |
8.7K |
6 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
25
|
8.7K
|
6
|
|
ASX - By Stock
|
LMG |
Re:
general discussion
|
|
Bpharma
|
2.4K |
1.1M |
5 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
5
|
|
ASX - By Stock
|
RCE |
Re:
[WEBINAR REPLAY] What it takes to get a new drug to market in Australia
|
|
Bpharma
|
32 |
11K |
1 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
32
|
11K
|
1
|
|
ASX - By Stock
|
LMG |
Re:
Ann: LMG Equity Raising Presentation
|
|
Bpharma
|
39 |
23K |
0 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
39
|
23K
|
0
|
|